0001628280-24-025011.txt : 20240523 0001628280-24-025011.hdr.sgml : 20240523 20240523171201 ACCESSION NUMBER: 0001628280-24-025011 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240521 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240523 DATE AS OF CHANGE: 20240523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ROCKWELL MEDICAL, INC. CENTRAL INDEX KEY: 0001041024 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 383317208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-23661 FILM NUMBER: 24979610 BUSINESS ADDRESS: STREET 1: 30142 WIXOM ROAD CITY: WIXOM STATE: MI ZIP: 48393 BUSINESS PHONE: 8004493353 MAIL ADDRESS: STREET 1: 30142 WIXOM ROAD CITY: WIXOM STATE: MI ZIP: 48393 FORMER COMPANY: FORMER CONFORMED NAME: ROCKWELL MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 20120530 FORMER COMPANY: FORMER CONFORMED NAME: ROCKWELL MEDICAL, INC. DATE OF NAME CHANGE: 20120525 FORMER COMPANY: FORMER CONFORMED NAME: ROCKWELL MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 19970722 8-K 1 rmti-20240521.htm 8-K rmti-20240521
0001041024FALSE00010410242024-05-212024-05-21

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  May 21, 2024
 
ROCKWELL MEDICAL, INC.
(Exact name of registrant as specified in its charter)
 
Delaware000-2366138-3317208
(State or other jurisdiction
of incorporation)		(Commission File Number)(IRS Employer
Identification No.)
 
30142 S. Wixom Road, Wixom, Michigan 48393
(Address of principal executive offices, including zip code)
 
(248) 960-9009
(Registrant’s telephone number, including area code)
 
N/A
(Former name or former address, if changed since last report)
  
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class Trading Symbol Name of Each exchange on which registered
Common Stock, par value $0.0001 RMTI 
Nasdaq Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☐


 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 




Item 5.07        Submission of Matters to a Vote of Security Holders.

On May 21, 2024, Rockwell Medical, Inc. held its 2024 Annual Meeting of the Stockholders (the "Annual Meeting"). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results were as follows:
Proposal One: To elect the two Class III directors to serve for a three-year term expiring at the 2027 annual meeting of stockholders and until his successor has been duly elected and qualified.

ForAgainstAbstainBroker Non-Votes
Robert S. Radie11,524,139 160,366 48,056 8,117,274 
Mark Strobeck, Ph.D.11,517,800 164,730 50,031 8,117,274 

Proposal Two: To approve, on an advisory basis, the compensation of the Company's named executive officers.
ForAgainstAbstainBroker Non-Votes
11,126,598 522,245 83,718 8,117,274 

Proposal Three: To ratify the selection of EisnerAmper LLP as the Company’s independent registered public accounting firm for 2024.
ForAgainstAbstain
19,446,483 210,240 193,112 





SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 ROCKWELL MEDICAL, INC.
   
Date: May 23, 2024By: /s/ Mark Strobeck
  Mark Strobeck
  Chief Executive Officer

 EX-101.SCH 2 rmti-20240521.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 rmti-20240521_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications City Area Code City Area Code Cover [Abstract] Cover [Abstract] Title of 12(b) Security Title of 12(b) Security Document Type Document Type Amendment Flag Amendment Flag Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Document Period End Date Document Period End Date Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 4 rmti-20240521_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover
May 21, 2024
Cover [Abstract]  
Document Type 8-K
Entity Registrant Name ROCKWELL MEDICAL, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 000-23661
Entity Tax Identification Number 38-3317208
Entity Address, City or Town Wixom
Entity Address, State or Province MI
Entity Address, Postal Zip Code 48393
City Area Code 248
Local Phone Number 960-9009
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001
Trading Symbol RMTI
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001041024
Amendment Flag false
Document Period End Date May 21, 2024
Entity Address, Address Line One 30142 S. Wixom Road
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://rockwellmed.com/role/Cover Cover Cover 1 false false All Reports Book All Reports rmti-20240521.htm rmti-20240521.xsd rmti-20240521_lab.xml rmti-20240521_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "rmti-20240521.htm": { "nsprefix": "rmti", "nsuri": "http://rockwellmed.com/20240521", "dts": { "inline": { "local": [ "rmti-20240521.htm" ] }, "schema": { "local": [ "rmti-20240521.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] }, "labelLink": { "local": [ "rmti-20240521_lab.xml" ] }, "presentationLink": { "local": [ "rmti-20240521_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2022": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 22 }, "report": { "R1": { "role": "http://rockwellmed.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "rmti-20240521.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "rmti-20240521.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AmendmentFlag", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CityAreaCode", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentPeriodEndDate", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentType", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressAddressLine1", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressCityOrTown", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityCentralIndexKey", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityFileNumber", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityRegistrantName", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "LocalPhoneNumber", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementTenderOffer", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "Security12bTitle", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SecurityExchangeName", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SolicitingMaterial", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "TradingSymbol", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "WrittenCommunications", "presentation": [ "http://rockwellmed.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 14 0001628280-24-025011-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-24-025011-xbrl.zip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end XML 16 rmti-20240521_htm.xml IDEA: XBRL DOCUMENT 0001041024 2024-05-21 2024-05-21 0001041024 false 8-K 2024-05-21 ROCKWELL MEDICAL, INC. DE 000-23661 38-3317208 30142 S. Wixom Road Wixom MI 48393 248 960-9009 false false false false Common Stock, par value $0.0001 RMTI NASDAQ false